MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Corcept Therapeutics Incorporated Company Profile (NASDAQ:CORT)

Consensus Ratings for Corcept Therapeutics Incorporated (NASDAQ:CORT) (?)
Ratings Breakdown: 3 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $10.67 (97.53% upside)

Analysts' Ratings History for Corcept Therapeutics Incorporated (NASDAQ:CORT)
Show:
DateFirmActionRatingPrice TargetActions
5/4/2016FBR & Co.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/29/2015Piper JaffrayReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/17/2015Janney Montgomery ScottInitiated CoverageBuy$8.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/30/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha